Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial.
A multicenter, randomised, blind comparision of amrinone with milrinone after elective cardiac surgery.
This launch is the first part of an alliance in which Taylor and Baxter will jointly develop, manufacture and market four injectable products with current sales in excess of $200 million: Ketorolac Tromethamine Injection, Amrinone
Lactate Injection, Diltiazem HCl Injection and Labetalol HCl Injection.
A related phosphodiesterase inhibitor, amrinone (6) increased free flap blood flow in a small group of patients when administered intravenously and decreased vasospasm when applied topically.
It has been shown that amrinone, a related PDE-III inhibitor, experimentally improves perfusion in free flaps (9), presumably by a combination of vasodilation and improved cardiac output.
The inotropic effects of amrinone
and milrinone on neonatal and young canine cardiac muscle.